Extract from the Register of European Patents

EP About this file: EP1940351

EP1940351 - SUSTAINED RELEASE SMALL MOLECULE DRUG FORMULATION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  08.02.2013
Database last updated on 01.04.2026
Most recent event   Tooltip19.07.2013Lapse of the patent in a contracting state
New state(s): BG
published on 21.08.2013  [2013/34]
Applicant(s)For all designated states
Durect Corporation
10260 Bubb Road
Cupertino, CA 95014 / US
[2012/13]
Former [2008/28]For all designated states
Alza Corporation
1900 Charleston Road M10-3B, Patent Law
Mountain View, CA 94043 / US
Inventor(s)01 / LUK, Andrew, S.
6512 Crestwood Drive
Castro Valley, CA 94552 / US
02 / JUNNARKAR, Gunjan, H.
720 Coastland Drive
Palo Alto, CA 94303 / US
03 / CHEN, Guohua
399 Sunset Avenue
Sunnyvale, CA 94086 / US
 [2008/28]
Representative(s)Woods, Geoffrey Corlett
J A Kemp
14 South Square
Gray's Inn
London WC1R 5JJ / GB
[N/P]
Former [2012/14]Woods, Geoffrey Corlett
J.A. Kemp & Co. 14 South Square Gray's Inn London
WC1R 5JJ / GB
Former [2008/29]Woods, Geoffrey Corlett
J.A. KEMP & CO. 14 South Square Gray's Inn London
WC1R 5JJ / GB
Former [2008/28]Woods, Geoffrey Corlett
J.A. KEMP & CO. 14 South Square Gray's Inn
London WC1R 5JJ / GB
Application number, filing date06825283.228.09.2006
[2008/28]
WO2006US38268
Priority number, dateUS20050722845P30.09.2005         Original published format: US 722845 P
[2008/28]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2007041410
Date:12.04.2007
Language:EN
[2007/15]
Type: A2 Application without search report 
No.:EP1940351
Date:09.07.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 12.04.2007 takes the place of the publication of the European patent application.
[2008/28]
Type: B1 Patent specification 
No.:EP1940351
Date:04.04.2012
Language:EN
[2012/14]
Search report(s)International search report - published on:EP12.07.2007
ClassificationIPC:A61K9/00
[2008/28]
CPC:
A61K31/519 (EP,US); A61K31/341 (EP,US); A61K47/10 (EP,US);
A61K47/14 (EP,US); A61K47/22 (EP,US); A61K47/34 (EP,US);
A61K51/1213 (US); A61K9/0019 (US); A61K9/0024 (EP,US);
A61K9/06 (US); A61K9/1617 (US); A61K9/1647 (US);
A61P25/18 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/28]
TitleGerman:KLEINMOLEKÜLIGE HEILMITTELFORMULIERUNG MIT VERZÖGERTER FREISETZUNG[2008/28]
English:SUSTAINED RELEASE SMALL MOLECULE DRUG FORMULATION[2008/28]
French:FORMULATION DE MEDICAMENTS A PETITES MOLECULES A LIBERATION PROLONGEE[2008/28]
Entry into regional phase28.03.2008National basic fee paid 
28.03.2008Designation fee(s) paid 
28.03.2008Examination fee paid 
Examination procedure08.05.2007Request for preliminary examination filed
International Preliminary Examining Authority: EP
28.03.2008Examination requested  [2008/28]
16.06.2008Amendment by applicant (claims and/or description)
17.04.2009Despatch of a communication from the examining division (Time limit: M04)
11.08.2009Reply to a communication from the examining division
12.10.2011Communication of intention to grant the patent
20.02.2012Fee for grant paid
20.02.2012Fee for publishing/printing paid
Divisional application(s)EP11162857.4  / EP2361609
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  17.04.2009
Opposition(s)07.01.2013No opposition filed within time limit [2013/11]
Fees paidRenewal fee
15.09.2008Renewal fee patent year 03
11.09.2009Renewal fee patent year 04
14.09.2010Renewal fee patent year 05
29.09.2011Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY04.04.2012
CZ04.04.2012
EE04.04.2012
LT04.04.2012
LV04.04.2012
PL04.04.2012
RO04.04.2012
SI04.04.2012
SK04.04.2012
BG04.07.2012
GR05.07.2012
IS04.08.2012
PT06.08.2012
MC30.09.2012
[2013/34]
Former [2013/20]CY04.04.2012
CZ04.04.2012
EE04.04.2012
LT04.04.2012
LV04.04.2012
PL04.04.2012
RO04.04.2012
SI04.04.2012
SK04.04.2012
GR05.07.2012
IS04.08.2012
PT06.08.2012
MC30.09.2012
Former [2013/10]CY04.04.2012
CZ04.04.2012
EE04.04.2012
LT04.04.2012
LV04.04.2012
PL04.04.2012
RO04.04.2012
SI04.04.2012
SK04.04.2012
GR05.07.2012
IS04.08.2012
PT06.08.2012
Former [2013/09]CY04.04.2012
EE04.04.2012
LT04.04.2012
LV04.04.2012
PL04.04.2012
SI04.04.2012
GR05.07.2012
IS04.08.2012
PT06.08.2012
Former [2013/01]CY04.04.2012
LT04.04.2012
LV04.04.2012
PL04.04.2012
SI04.04.2012
GR05.07.2012
IS04.08.2012
PT06.08.2012
Former [2012/50]CY04.04.2012
LT04.04.2012
LV04.04.2012
PL04.04.2012
SI04.04.2012
GR05.07.2012
IS04.08.2012
Former [2012/49]CY04.04.2012
LT04.04.2012
PL04.04.2012
SI04.04.2012
IS04.08.2012
Former [2012/47]LT04.04.2012
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.